Integral Diagnostics Limited (ASX: IDX) — Stock Profile


About IDX (ASX: IDX)

Integral Diagnostics Limited operates as a healthcare services provider, delivering diagnostic imaging to general practitioners, medical specialists and allied health professionals, along with their patients, across Australia and New Zealand. Its service offering spans magnetic resonance imaging, positron emission tomography, computed tomography, mammography, interventional radiology, ultrasound and radiography including x-ray and EOS imaging, making it a broad-based provider covering most major diagnostic imaging modalities used in referral-based clinical practice.

The group's imaging network gives referring clinicians access to both routine and advanced procedures, from standard radiography and ultrasound through to higher-end modalities such as MRI and PET, along with EOS low-dose imaging and interventional radiology services that support more complex diagnostic and procedural needs. Integral Diagnostics was founded in 1967 and today operates as an established participant in the Australian and New Zealand diagnostic imaging sector, with its head office located in Melbourne, Australia.


MFAM Research

No mfam research yet.


Latest Announcements

  • IDX (ASX: IDX) – New Chief Executive and Managing Director Appointment
    August 6, 2026
    Integral Diagnostics Limited (ASX: IDX) has formally commenced the tenure of Jason Martinez as Managing Director and Chief Executive Officer on 6 August 2026, following the completion of his obligations to his previous employer. The appointment, which was announced to the market on 10 November 2025, represents a significant leadership transition for the diagnostic imaging […]

Financial Summary


Price History


Share This